The Society of Nuclear Medicine recently conducted a survey of nuclear pharmacies — pharmacies that supply the critical radioisotope Technetium-99m, which is used in more than 16 million nuclear medicine tests each year in the United States — to assess, anecdotally, the impact of the worldwide medical isotope shortage.